Announce Date | 04/28/2024 |
EPS Normalized Actual | $-1.6 (Beat by $5) |
EPS GAAP Actual | $-1.6 (Beat by $5) |
Revenue Actual | $0.053399B |
Revenue Surprise | Beat by $53.399M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-6.3 |
EPS GAAP Estimate | $-6.3 |
Revenue Estimate | $0.081000609B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2030 | 0.6 | 0.98 | 0.6 | 0.6 | 1 |
Dec 2029 | 0.5 | 1.18 | 0.5 | 0.5 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2021 (Jun 2021) | 2.18 | 2.18 | 0.053399B | 100% | 53.4M |
FQ3 2021 (Sep 2021) | -0.78 | -0.78 | 0.04281B | 100% | 42.81M |
FQ4 2021 (Dec 2021) | 1.66 | 1.66 | 0.047425B | 100% | 47.43M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
-6.3
Consensus Revenue Estimates
0.081000609B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.1 | -- | 1.1 | 1.1 | 1 |
FQ2 2027 (Jun 2027) | 1.1 | -- | 1.1 | 1.1 | 0 |
FQ1 2027 (Mar 2027) | 1.1 | -- | 1.1 | 1.1 | 0 |
FQ4 2026 (Dec 2026) | -3.3 | -- | -3.3 | -3.3 | 0 |
FQ3 2026 (Sep 2026) | 5 | -- | 5 | 5 | 0 |
FQ2 2026 (Jun 2026) | -2.3 | -- | -2.3 | -2.3 | 0 |
FQ1 2026 (Mar 2026) | -1.1 | -- | -1.1 | -1.1 | 0 |
FQ4 2025 (Dec 2025) | -1.7 | -- | -1.7 | -1.7 | 0 |
FQ3 2025 (Sep 2025) | -6.3 | -- | -6.3 | -6.3 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.11B | -- | 0.11B | 0.11B | 1 |
FQ2 2027 (Jun 2027) | 0.1B | -- | 0.1B | 0.1B | 0 |
FQ1 2027 (Mar 2027) | 0.1B | -- | 0.1B | 0.1B | 0 |
FQ4 2026 (Dec 2026) | 0.1B | -- | 0.1B | 0.1B | 0 |
FQ3 2026 (Sep 2026) | 0.09B | -- | 0.09B | 0.09B | 0 |
FQ2 2026 (Jun 2026) | 0.09B | -- | 0.09B | 0.09B | 0 |
FQ1 2026 (Mar 2026) | 0.09B | -- | 0.09B | 0.09B | 0 |
FQ4 2025 (Dec 2025) | 0.08B | -- | 0.08B | 0.08B | 0 |
FQ3 2025 (Sep 2025) | 0.08B | -- | 0.08B | 0.08B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2021 (Jun 2021) | 2.18 | 2.18 | 100% | |
FQ3 2021 (Sep 2021) | -0.78 | -0.78 | 100% | |
FQ4 2021 (Dec 2021) | 1.66 | 1.66 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2021 (Jun 2021) | $0B | $0.05B | $53.4M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.04B | $42.81M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.05B | $47.43M | 100% |